logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Primary drug and age. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (v) Age distribution, New inpatient clients (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.05.519.425.021.613.98.36.331.230120
Cocaine0.55.417.623.521.413.59.58.732.06540
Stimulants0.318.730.224.615.66.52.41.726.312151
Hypnotics and sedatives0.23.713.012.612.310.09.838.440.54301
Hallucinogens0.025.623.327.916.34.72.30.025.4430
Volatile substances7.454.515.710.78.31.71.70.021.01210
Cannabis 1.524.529.019.711.76.93.03.725.917201
Other substances 0.919.228.220.712.06.22.310.528.55321
Total0.613.523.322.417.010.15.87.129.477274
 

Notes

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI outpatient and inpatient treatment centres.

Page last updated: Friday, 26 April 2013